DOI QR코드

DOI QR Code

Lack of Sunlight Exposure Influence on Primary Glioblastoma Survival

  • Mutlu, Hasan (Department of Medical Oncology, Akdeniz University School of Medicine) ;
  • Akca, Zeki (Department of Radiation Oncology, Mersin Government Hospital) ;
  • Erden, Abdulsamet (Department of Internal Medicine, Kayseri Research and Training Hospital) ;
  • Aslan, Tuncay (Department of Internal Medicine, Kayseri Research and Training Hospital) ;
  • Ucar, Kadir (Department of Radiation Oncology, Acıbadem Kayseri Hospital) ;
  • Kaplan, Bunyamin (Department of Radiation Oncology, Acıbadem Kayseri Hospital) ;
  • Buyukcelik, Abdullah (Department of Internal Medicine, Acıbadem University School of Medicine)
  • Published : 2014.05.30

Abstract

Background: The prognosis of primary glioblastoma (GBM) is poor. Approximately 2/3 of primary brain tumor diagnoses are GBM, of which 95% are primary lesions. In this study, we aimed to evaluate whether more sunlight exposure has an effect on survival of patients with primary GBM. Materials and Methods: A total of 111 patients with primary GBM were enrolled from Kayseri in inner Anatolia which has a cold climate (n: 40) and Mersin in Mediterranean region with a warm climate and more sunlight exposure (n: 71). The patients with primary GBM were divided into two groups as Kayseri and Mersin and compared for progression free survival (PFS) and overall survival (OS).Results: The PFS values were 7.0 and 4.7 months for Kayseri and Mersin groups, respectively (p=0.10) and the repsective OS values were 13.3 and 9.4 months (p=0.13). We did not found any significant difference regarding age, sex, comorbidity, smoking, surgery, resurgery, adjuvant chemoradiotherapy and palliative chemotherapy between the groups. Conclusions: We found that more sunlight exposure had no impact on prognosis of patients with primary GBM, adding inconsistency to the literature about the relationship between sunlight and GBM.

Keywords

References

  1. Ahmed R, Oborski MJ, Hwang M, Lieberman FS, Mountz JM (2014). Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods. Cancer Manag Res, 24, 149-70.
  2. Baudet C, Chevalier G, Naveihan P, et al (1996). Cytotoxic effects of 1a,25-dihydroxyvitamin D3 and synthetic vitamin D3 analogues on a glioma cell line. Cancer Lett, 100, 3-10. https://doi.org/10.1016/0304-3835(95)04054-4
  3. Bhurgri Y, Bhurgri H, Kayani N, et al (2011). Trends and morphology of central nervous system malignancies in Karachi. Asian Pac J Cancer Prev, 12, 2013-7.
  4. Braganza MZ, Kitahara CM, Berrington de Gonzalez A, et al (2012). Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro Oncol, 14, 1316-24. https://doi.org/10.1093/neuonc/nos208
  5. Brenner AV, Linet MS, Shapiro WR, et al (2004). Season of birth and risk of brain tumors in adults. Neurology, 63, 276-81. https://doi.org/10.1212/01.WNL.0000129984.01327.9D
  6. Chen H, Ward MH, Tucker KL, et al (2002). Diet and risk of adult glioma in eastern Nebraska, United States. Cancer Causes Control, 13, 647-55. https://doi.org/10.1023/A:1019527225197
  7. Ding LX, Wang YX (2011). Increasing incidence of brain and nervous tumours in urban Shanghai, China, 1983-2007. Asian Pac J Cancer Prev, 12, 3319-22.
  8. Efird JT (2011). Season of birth and risk for adult onset glioma. Int J Environ Res Public Health, 7, 1913-36.
  9. Furnari FB, Fenton T, Bachoo RM, et al (2007). Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev, 21, 2683-710. https://doi.org/10.1101/gad.1596707
  10. Giles GG, McNeil JJ, Donnan G, et al (1994). Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia. Int J Cancer, 59, 357-62. https://doi.org/10.1002/ijc.2910590311
  11. Grant WB (2012). Ecological studies of the UVB-vitamin D-cancer hypothesis. Anticancer Res, 32, 223-36.
  12. Hakko H, Rasanen P, Niemela A, Koivukangas J, Mainio A (2009). Season of tumor surgery in relation to deaths among brain tumor patients: does sunlight and month of surgery play a role in brain tumor deaths? Acta Neurochir, 151, 1369-75. https://doi.org/10.1007/s00701-009-0438-7
  13. Hyun MK, Hwang JS, Kim JH, et al (2013). Survival outcomes after whole brain radiation therapy and/or stereotactic radiosurgery for cancer patients with metastatic brain tumors in Korea: a systematic review. Asian Pac J Cancer Prev, 14, 7401-7. https://doi.org/10.7314/APJCP.2013.14.12.7401
  14. Inskip PD, Mellemkjaer L, Gridley G, Olsen JH (1998). Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control, 9, 109-16. https://doi.org/10.1023/A:1008861722901
  15. Magrassi L, Adorni L, Montorfano G, et al (1998). Vitamin D metabolites activate the sphingomyelin pathway and induce death of glioblastoma cells. Acta Neurochir (Wien), 140, 707-13. https://doi.org/10.1007/s007010050166
  16. Mainio A, Hakko H, Koivukangas J, Niemela A, Rasanen P (2006). Winter birth in association with a risk of brain tumor among a Finnish patient population. Neuroepidemiology, 27, 57-60. https://doi.org/10.1159/000094578
  17. Manoharan N, Julka PK, Rath GK (2012). Descriptive of primary brain and CNS tumors in Delhi, 2003-2007. Asian Pac J Cancer Prev, 13, 637-40. https://doi.org/10.7314/APJCP.2012.13.2.637
  18. Muallaoglu S, Besen AA, Ata A, et al (2014). Lack of prognostic significance of C-erbB-2 expression in low- and high- grade astrocytomas. Asian Pac J Cancer Prev, 15, 1333-7. https://doi.org/10.7314/APJCP.2014.15.3.1333
  19. Musicco M, Sant M, Molinari S, et al (1988). A case-control study of brain gliomas and occupational exposure to chemical carcinogens: the risk to farmers. Am J Epidemiol, 128, 778-85.
  20. Naveilhan P, Berger F, Haddad K, et al (1994). Induction of glioma cell death by 1,25 (OH)2 vitamin D3: towards an endocrine therapy of brain tumors? J Neurosci Res, 37, 271-7. https://doi.org/10.1002/jnr.490370212
  21. Parsons DW, Jones S, Zhang X, et al (2008). An integrated genomic analysis of human glioblastoma multiforme. Science, 321, 1807-12. https://doi.org/10.1126/science.1164382
  22. Preston-Martin S (1989). Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges in Los Angeles County. Neuroepidemiology, 8, 283-95. https://doi.org/10.1159/000110196
  23. Reardon DA, Wen PY (2006) Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents. Oncologist, 11, 152-64. https://doi.org/10.1634/theoncologist.11-2-152
  24. Savitz DA, Loomis DP (1995). Magnetic field exposure in relation to leukemia and brain cancer mortality among electric utility workers. Am J Epidemiol, 141, 123-34.
  25. Schwartzbaum J, Ding B, Johannesen TB, et al (2012). Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst, 104, 1251-9. https://doi.org/10.1093/jnci/djs315
  26. Stupp R, Mason WP, van den Bent MJ, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 352, 987-96. https://doi.org/10.1056/NEJMoa043330
  27. Yang L, Veierod MB, Lof M, et al (2011). Prospective study of UV exposure and cancer incidence among Swedish women. Cancer Epidemiol Biomarkers Prev, 20, 1358-67. https://doi.org/10.1158/1055-9965.EPI-11-0071
  28. Zeybek U, Yaylim I, Ozkan NE, et al (2013). Cyclin D1 gene G870A variants and primary brain tumors. Asian Pac J Cancer Prev, 14, 4101-6. https://doi.org/10.7314/APJCP.2013.14.7.4101